It's no secret that Broncho-Munal turned out to be the most popular bacterial lysate obtained as a result of lyophilization. And I hardly joke.
The manufacturer of Broncho-Munal first lyophilized the bacterial lysates, and then invested heavily in their promotion.
Multiplying all this on our domestic pulmonologists, extremely sensitive to the advancement, we get... exactly what we get.
This could have ended.
But I would like to add something.
Well what the hell?! What are bacterial lysates? How many are there? Thirty-five milligrams per capsule? So what? And why?
We have kilograms of microbes living in our intestines, which die continuously and turn into the very lysates. Kilograms of lysates. Why are we not immunized with them then?
Well, we wouldn't be sick then with cystitis and pyelonephritis. The causative agent of our cystitis with pyelonephritis lives in our intestines. And yes, we ourselves continuously digest it into bacterial lysate. But for some reason we continue to get sick with cystitis and pyelonephritis.
If you have questions about preventing exacerbations of chronic obstructive pulmonary disease, then read the "Global strategy for diagnosis, treatment and prevention of chronic obstructive disease lungs ". There is now a 2020 revision.
This thing has been claimed by hundreds of experts around the world. There even our usually about twenty participate. About 150 pages of text.
There, in one place, immunomodulators from bacterial lysates are casually mentioned. Like there is such a thing, but have not yet decided what is the use of it. And that's all.
These are the global things to be guided by, and not to a separate pulmonologist who read the advertising booklet of the drug manufacturer.
In short, the effect of bacterial lysates in the prevention of exacerbations of chronic lung diseases has not been studied to date. So do not bother and do not waste your money.
Or have you already spent?
